PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)
China flag China · Delayed Price · Currency is CNY
54.38
+4.87 (9.84%)
Aug 20, 2026, 3:04 PM CST

SHE:300725 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
647.68532.74290.2511.191,150699.63
Short-Term Investments
488.18351.85618.48984.26303.46100.74
Trading Asset Securities
592.96735.57465.61105.35163.3304.43
Cash & Short-Term Investments
1,7291,6201,3741,6011,6171,105
Cash Growth
3.79%17.89%-14.15%-1.01%46.38%-19.79%
Accounts Receivable
381.72386.03483.69473.66330.61201.27
Other Receivables
4.442.991.922.621.832.11
Receivables
386.16389.02485.61476.28332.44203.38
Inventory
713.6655.24840.17724.79676.39447.94
Other Current Assets
17.3111.3416.8815.8833.847.89
Total Current Assets
2,8462,6762,7172,8182,6601,804
Property, Plant & Equipment
1,7431,6531,6841,7531,6611,173
Long-Term Investments
126.822,30319.865.485.668.91
Goodwill
355.74355.74355.74356.19356.19356.19
Other Intangible Assets
101.31103.59107.98109.42111.48111.47
Long-Term Deferred Tax Assets
36.5939.8232.6338.6135.815.1
Long-Term Deferred Charges
31.9610.136.9410.149.187.24
Other Long-Term Assets
142.25198.310.9913.122.830.74
Total Assets
5,3837,3404,9355,1044,8623,507

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
429.53312.75292.2278.7413.47267.35
Accrued Expenses
89.37111.291104.7188.1860.61
Short-Term Debt
100.06100.06230.27236.5163.4347.64
Current Portion of Long-Term Debt
--52.74371.4317.297.95
Current Portion of Leases
7.114.751.261.99-1.82
Current Income Taxes Payable
16.1814.6716.9615.70.850.15
Current Unearned Revenue
71.2970.2856.2832.7339.6328.7
Other Current Liabilities
8.88.118.5314.3316.3574.66
Total Current Liabilities
722.34621.82749.231,056739.18788.88
Long-Term Debt
--1,1271,1381,39223.6
Long-Term Leases
14.687.873.210.23--
Long-Term Unearned Revenue
41.3444.846.6152.6452.8554.14
Long-Term Deferred Tax Liabilities
39.29365.2522.1324.3120.1512.58
Total Liabilities
817.651,0401,9482,2722,205879.21

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
233.81233.81199.73199.66199.66199.7
Additional Paid-In Capital
2,3382,3381,0961,0901,0751,299
Retained Earnings
1,9461,8241,5971,4391,261967.1
Treasury Stock
-30.04-30.04-30.04-20.03--35
Comprehensive Income & Other
78.791,935125.24123.52121.74-3.44
Total Common Equity
4,5666,3002,9882,8322,6582,427
Minority Interest
----0200.29
Shareholders' Equity
4,5666,3002,9882,8322,6582,628
Total Liabilities & Equity
5,3837,3404,9355,1044,8623,507

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
121.85112.671,4141,7491,573381.02
Net Cash (Debt)
1,6071,507-39.71-147.8344.11723.78
Net Cash Growth
468.22%----93.91%-42.42%
Net Cash Per Share
7.187.22-0.20-0.730.223.63
Filing Date Shares Outstanding
232.97232.97198.89198.83199.66199.7
Total Common Shares Outstanding
232.97232.97198.89198.83199.66199.7
Working Capital
2,1242,0541,9681,7621,9211,015
Book Value Per Share
19.6027.0415.0214.2413.3112.16
Tangible Book Value
4,1095,8412,5242,3672,1901,960
Tangible Book Value Per Share
17.6425.0712.6911.9010.979.81
Buildings
982.88949.96950.4905.31844.6344.88
Machinery
1,3371,3031,0521,025792.72510.13
Construction In Progress
140.8561.68232.68256.23357.53575.32